Panacea Biotec, the country’s third largest biotechnology company has introduced indigenously developed high quality anti-diabetic drug, TENEPAN (Teneligliptin), for treatment of Type 2 Diabetes Mellitus (T2DM). TENEPAN (Teneligliptin) aims to improve accessibility of this treatment for the benefit of patients at an affordable cost as part of company’s commitment to Government of India’s ‘Make in India’ mission.
Panacea Biotec is the third largest biotechnology company as well as among the top 50 pharmaceutical companies of India. The company has product portfolio that’s caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal.
